MAPT and Alzheimer disease: It is worth mentioning that other AD biomarkers, such as YKL–40, neurofilament light (NfL), glial fibrillary protein (GFAP) and total tau protein have been quantified in saliva samples and have shown to be readily detected [13], [26], [46].